CardioComm Solutions, Inc. EKG.V
Health Care · Health Care Equipment & Services · TSX-V · Canada · cardiocommsolutions.com
CardioComm Solutions, Inc. develops software, hardware, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. Its products include the GEMS remote patient monitoring platform and HeartCheck mobile ECG devices, with regulatory clearances from Health Canada, the FDA, and European CE Mark. The company is headquartered in Toronto, Canada.
Key ratios
FreeCashFlowOnSale TTM -1.16
FreeCashFlowOnSale 2024 -0.22
FreeCashFlowOnSale 2023 -0.06
FreeCashFlowOnSale 2022 0.04
NetIncomeMargin TTM -1.1
NetIncomeMargin 2024 -0.37
NetIncomeMargin 2023 -0.11
NetIncomeMargin 2022 -0
ReturnOnAssets TTM -0.91
ReturnOnAssets 2024 -0.51
ReturnOnAssets 2023 -0.28
ReturnOnAssets 2022 -0.04
Recent news
CardioComm Solutions and Predictiv AI Enter into Strategic AI Collaboration
2026-06-08 · Newsfile Corp
CardioComm Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933
2026-05-08 · Newsfile Corp
CardioComm Solutions Announces Royalty-Based Financing Deal
2025-10-01 · Newsfile Corp